ABSTRACT: Ramosetron hydrochloride is the hydrochloride salt of ramosetron, a selective serotonin (5-HT3) receptor antagonist with potential antiemetic activity. Upon administration, ramosetron selectively binds to and blocks the activity of 5-HT subtype 3 (5-HT3) receptors located in the vagus nerve terminal and the vomiting center of central nervous system (CNS), suppressing chemotherapy-induced nausea and vomiting. Degradation of Ramosetron HCl was conducted with 0.1N NaOH at 60°C, 70°C and 80°C to study the reaction kinetics. The reaction rate constants (k) for degradation at 60°C, 70°C and 80°C were -2. 
INTRODUCTION
The purpose of stability testing is to provide evidence on how the quality of a drug substance or drug product varies with time under the influence of a variety of environmental stress factors, such as temperature, humidity, and light. Stability testing is also important to establish a retest period for the drug substance during the shelf life for the drug product and recommended storage conditions. 1, 2 The rate and mechanisms of reactions with particular emphasis on decomposition and stabilization of drug products are essential for formulation scientists to study, understand, and interpret conditions of instability of pharmaceuticals products as well as to be able to offer solutions for the stabilization of these products. 3 Knowing the rate at which a drug deteriorates at various hydrogen ion concentrations allows one to choose a vehicle that will retard or prevent the degradation. 4 Application of degradation kinetics in formulation results in the production of more stable , and Palonosetron HCl 13 influence the research intuition to take Ramosetron HCl under kinetics studies.
MATERIALS AND METHODS
Drug substance and reagents. Pure Ramosetron hydrochloride (SMS Pharmaceutical Ltd., India), was obtained from Incepta Pharmaceuticals Ltd. (Dhaka, Bangladesh). Methanol (HPLC grade), acetonitrile (HPLC grade), triethylamine (reagent grade), hydrogen peroxide, dipotassium hydrogen phosphate anhydrous (reagent grade) and sodium hydroxide (reagent grade) were purchased from Scharlau (Scharlau S.L., Spain). HPLC grade water was prepared by PALL purification system (PALL, Cascada AN, USA). Hydrochloric acid (37% commercial grade) and orthophosphoric acid (reagent grade) were purchased from Labscan (ACI Labscan, Thailand).
Equipments. An Agilent Technologies 1260 series HPLC system (Agilent, Infinity 1260, Germany) equipped with integral autosampler (model 1260 HiP ALS) and quaternary gradient pump (model Quat Pump VL) with an on-line degasser were used. The column compartment (model 1260 TCC) having temperature control and a diode array detector (model 1260 DAD VL+) were employed throughout the analysis. Chromatographic data was acquired using Agilent OpenLAB software.
A hot air oven (Memmert, Mumbai, India) was used to maintain constant temperature. An ultrasonicator from Power Sonic-405 (Hwashin Technology, Seoul, Korea) and pH meter from pH tutor (Eutech Instruments, Singapore) were used.
Chromatographic conditions. Chromatographic separation was achieved at a temperature of 40°C on a cyano bonded silica column (250 x 4.6 mm; CN; Kromasil) using a mobile phase comprising of a mixture of acetonitrile -methanol -buffer (50 mM dipotassium hydrogen phosphate anhydrous containing 1 ml of triethylamine per liter with pH 7.0 adjusted by diluted orthophophoric acid) in the ratio ( 3 : 1 : 6 ). The mobile phase so prepared was filtered through 0.45 μm membrane filter and degassed by sonication. Flow rate was maintained at 1.0 ml/min was maintained. The injection volume was 20 μL for all the analyses. The detection was carried out at 210 nm.
Procedure for degradation kinetics studies.
Degradation kinetics of the drug substance was conducted in basic condition (0.1N NaOH) at 60°C, 70°C and 80°C for 1, 2, 3, 4 and 5 hours. The concentration of the solution kept for degradation under different time intervals was 1.0 mg/ml. The final concentration of the degraded samples was 0.2 mg/ml in mobile phase.
To explain kinetics of degradation and to find out the best fitness of the regression coefficient, the relationship between the concentration vs time was drawn for zero, first and second order reaction following Eq. 1, 2, and 3 respectively. Eq. 4 was used to calculate activation energy where, C t and C o are the concentrations at time t and zero, respectively. The reaction rate constant for zero, first and second order reactions were k o , k 1 and k 2, respectively. E a is the reaction activation energy, A is the frequency factor, R is the molar gas constant and T is the temperature in Kelvin. Preparation of analytical sample for degradation kinetics. An aliquot of stock sample prepared for degradation kinetics study was diluted to 5 ml with 0.1N NaOH in five different volumetric flasks to get a concentration of 1.0 mg/ml. These solutions were kept in a dry oven at 60°C, 70°C and 80°C for 1, 2, 3, 4, and 5 hours. These degraded samples were neutralized with equimolar strength and volume of hydrochloric acid respectively before further dilution with mobile phase to get a final concentration of 0.2 mg/ml. The linearity graph required to calculate reaction activation energy (E a ) was derived from reaction rate constant (k) vs inverse temperature in Kelvin (1/T). This linearity graph is shown in figure 7 . All HPLC chromatograms relevant to degraded samples are presented in figures 1-3. 
RESULTS AND DISCUSSION

CONCLUSION
Kinetic parameters such as activation energy, Ea, reactant half-life, t 1/2 , reactant shelf-life, t 90 , and reaction rate constant, k, are used extensively to calculate the retest period of a drug substance and to set expiration date and stability condition over the period of shelf-life. Degradation kinetic study revealed that the activation energy of Ramosetron hydrochloride is 10.05 kcalmol -1 . Considering the best fit regression coefficient (R 2 ) value, one can easily calculate reaction order to find out reaction rate constant (k) used to calculate half-life and shelflife. Calculated half-life and shelf-life information help to set retest period of Ramosetron hydrochloride and also to predict shelf-life period of different dosage form of Ramosetron hydrochloride, specially lyophilized dosage form.
